Medroxyprogesterone at High Altitude. The Effects on Blood Gases
... acute mountain sickness (AMS). Design.—Two placebo-controlled trials during rapid ascent to high altitude. Participants.—In the first trial, 20 participants, and in the second trial, 24 participants. Setting.—During rapid ascent to 4680 m and on rapid ascent to 5200 m. Intervention.—In the first tri ...
... acute mountain sickness (AMS). Design.—Two placebo-controlled trials during rapid ascent to high altitude. Participants.—In the first trial, 20 participants, and in the second trial, 24 participants. Setting.—During rapid ascent to 4680 m and on rapid ascent to 5200 m. Intervention.—In the first tri ...
Effectiveness of salmeterol versus ipratropium bromide on exertional
... each patient was randomly assigned to receive two puffs (42 mg) of salmeterol and two puffs of an identical appearing placebo inhaler or two puffs (36 mg) of ipratropium bromide from each of two inhalers (total, 72 mg). All patients were familiar with use of a metered-dose inhaler (MDI) and had demo ...
... each patient was randomly assigned to receive two puffs (42 mg) of salmeterol and two puffs of an identical appearing placebo inhaler or two puffs (36 mg) of ipratropium bromide from each of two inhalers (total, 72 mg). All patients were familiar with use of a metered-dose inhaler (MDI) and had demo ...
product monograph
... Pediatrics (< 18 years of age) The safety and efficacy in patients under the age of 18 have not been established. (See ...
... Pediatrics (< 18 years of age) The safety and efficacy in patients under the age of 18 have not been established. (See ...
Hyperlipidemia
... administration times with an interval of 6 hours or greater between the BAR and other drugs. ...
... administration times with an interval of 6 hours or greater between the BAR and other drugs. ...
Drug prescribing pattern of topical corticosteroids
... from the previously described guidelines and usage criteria are very important steps. Then, the reasons for this deviation should be evaluated. For any drug utilization study to be successful, scientific interpretation of the results instead of a value judgment needs to be prepared and results of th ...
... from the previously described guidelines and usage criteria are very important steps. Then, the reasons for this deviation should be evaluated. For any drug utilization study to be successful, scientific interpretation of the results instead of a value judgment needs to be prepared and results of th ...
代表讲稿4
... adequate anesthesia and a broadspectrum topical microbicide monitoring for intraocular pressure, endophthalmitis(眼内炎) ...
... adequate anesthesia and a broadspectrum topical microbicide monitoring for intraocular pressure, endophthalmitis(眼内炎) ...
Ibavyr Datasheet 200, 400, 600mg
... triazole carboxylic acid metabolites is renal (accounting for about 5 – 15% of single dose elimination), with the majority of the dose eliminated as metabolites rather than as parent compound. Due to extensive distribution, the terminal half-life of a single oral dose is around 120 to 170 hours and ...
... triazole carboxylic acid metabolites is renal (accounting for about 5 – 15% of single dose elimination), with the majority of the dose eliminated as metabolites rather than as parent compound. Due to extensive distribution, the terminal half-life of a single oral dose is around 120 to 170 hours and ...
Rodent Anesthetics and Analgesics
... research due to anti‐inflammatory properties; COX‐1 side effects such as: gastrointestinal complications, prolonged coagulation times, and changes in kidney function with non‐COX‐2 selective forms. Additional Notes: Analgesic combinations that include NSAIDs plus opioids would be considered an ideal ...
... research due to anti‐inflammatory properties; COX‐1 side effects such as: gastrointestinal complications, prolonged coagulation times, and changes in kidney function with non‐COX‐2 selective forms. Additional Notes: Analgesic combinations that include NSAIDs plus opioids would be considered an ideal ...
Ibuprofen toxicosis in dogs, cats, and ferrets
... medulla’s blood flow, especially during hypovolemic states. Ibuprofen blocks these vasodilatory prostaglandins. The resultant diminished renal blood flow can lead to acute interstitial nephritis, papillary necrosis, renaltubular necrosis, and acute renal failure. Preexisting renal disease, hypovolem ...
... medulla’s blood flow, especially during hypovolemic states. Ibuprofen blocks these vasodilatory prostaglandins. The resultant diminished renal blood flow can lead to acute interstitial nephritis, papillary necrosis, renaltubular necrosis, and acute renal failure. Preexisting renal disease, hypovolem ...
Common errors in multidrug-resistant tuberculosis management
... of other treatments. Nevertheless, rifampicin and isoniazid resistance confirmation and species differentiation is always advisable [7,19,20]. In any case, the use of second-line drugs to treat susceptible TB is still a life-saving measure but implies consuming precious resources. Accelerating the c ...
... of other treatments. Nevertheless, rifampicin and isoniazid resistance confirmation and species differentiation is always advisable [7,19,20]. In any case, the use of second-line drugs to treat susceptible TB is still a life-saving measure but implies consuming precious resources. Accelerating the c ...
Role of antiarrhythmic drugs: frequent implantable cardioverter
... group compared to 3.89 ± 10.65 in control group. Rate of discontinuation of the drug was about 33% at one year in the sotalol and placebo groups. Patients receiving sotalol were more likely to have bradycardia and QT prolongation, but only one episode of torsades de pointes (TdP) was reported. Simil ...
... group compared to 3.89 ± 10.65 in control group. Rate of discontinuation of the drug was about 33% at one year in the sotalol and placebo groups. Patients receiving sotalol were more likely to have bradycardia and QT prolongation, but only one episode of torsades de pointes (TdP) was reported. Simil ...
Effects of Valproate on Male Reproductive Functions
... a result of the negative feedback mechanism. While there was no significant difference between the 2 drug groups in terms of FSH and LH, only in the CBZ group was a significant increase in mean serum SHBG concentration observed (Rattya et al., 2001a). It was suggested that this increase was associat ...
... a result of the negative feedback mechanism. While there was no significant difference between the 2 drug groups in terms of FSH and LH, only in the CBZ group was a significant increase in mean serum SHBG concentration observed (Rattya et al., 2001a). It was suggested that this increase was associat ...
ZOCOR - Merck.com
... simvastatin 80 mg chronically (e.g., for 12 months or more) without evidence of muscle toxicity [see Warnings and Precautions (5.1)]. Patients who are currently tolerating the 80-mg dose of ZOCOR who need to be initiated on an interacting drug that is contraindicated or is associated with a dose cap ...
... simvastatin 80 mg chronically (e.g., for 12 months or more) without evidence of muscle toxicity [see Warnings and Precautions (5.1)]. Patients who are currently tolerating the 80-mg dose of ZOCOR who need to be initiated on an interacting drug that is contraindicated or is associated with a dose cap ...
Metabolic bone diseases
... 2. Subcutaneous or intramuscular salmon calcitonin can be used if bisphosphonates therapy is contraindicated. ...
... 2. Subcutaneous or intramuscular salmon calcitonin can be used if bisphosphonates therapy is contraindicated. ...
Prevalence and predictors of potential drug
... In the cross sectional study was analyzed the data about outpatient prescriptions in city region Novi Sad, which is the administrative seat of the northern Serbian province of Vojvodina, with population of approximately 340000 individuals. Data were obtained from the electronic prescription database ...
... In the cross sectional study was analyzed the data about outpatient prescriptions in city region Novi Sad, which is the administrative seat of the northern Serbian province of Vojvodina, with population of approximately 340000 individuals. Data were obtained from the electronic prescription database ...
Cholestasis - Yorkshire and the Humber Deanery
... Usually acute, can be chronic Acute is usually in 5 to 90 days of starting drug Can occur after stopping causative drug Existing liver dysfunction does not increase risk of hepatotoxic reaction ...
... Usually acute, can be chronic Acute is usually in 5 to 90 days of starting drug Can occur after stopping causative drug Existing liver dysfunction does not increase risk of hepatotoxic reaction ...
Use of Thromboelastography (TEG) for Detection of New Oral
... available tests, including thrombin time, ecarin clotting time, Heptest (American Diagnostica, Stamford, Connecticut), prothrombinase-induced clotting time, and chromogenic factor IIa, either do not correlate well with drug levels or are cumbersome and lengthy to perform. The difficulty of managing ...
... available tests, including thrombin time, ecarin clotting time, Heptest (American Diagnostica, Stamford, Connecticut), prothrombinase-induced clotting time, and chromogenic factor IIa, either do not correlate well with drug levels or are cumbersome and lengthy to perform. The difficulty of managing ...
Introduction to Pharmacology Chapter 1
... • M3ß- and M6ß-glucoronides are primary metabolites – may contribute to analgesic effects (M6ß) and side-effects (M3ß) – lower dosing in geriatric patients (smaller Vd and renal function) ...
... • M3ß- and M6ß-glucoronides are primary metabolites – may contribute to analgesic effects (M6ß) and side-effects (M3ß) – lower dosing in geriatric patients (smaller Vd and renal function) ...
A. Treating the outpatient with severe ulcerative colitis: case studies
... • Immunologic mechanisms for the protective effect of cigarette smoking in UC remain unclear • Immunologic and clinical studies in IBD have focused on nicotine • Therapeutic trial experience in UC with nicotine gum, ...
... • Immunologic mechanisms for the protective effect of cigarette smoking in UC remain unclear • Immunologic and clinical studies in IBD have focused on nicotine • Therapeutic trial experience in UC with nicotine gum, ...
Vioxx Report.indd - The Physicians Committee
... Explicit statistical comparisons in the original protocol were altered, which, in combination with the expanded endpoint definition and shortened follow-up, allowed the authors to conclude that celecoxib was superior to ibuprofen and diclofenac in preventing GI complications. FDA review and data anal ...
... Explicit statistical comparisons in the original protocol were altered, which, in combination with the expanded endpoint definition and shortened follow-up, allowed the authors to conclude that celecoxib was superior to ibuprofen and diclofenac in preventing GI complications. FDA review and data anal ...
Nuedexta Prescribing Information
... symptoms, such as lightheadedness, chills, fever, nausea, and vomiting, can precede or occur with thrombocytopenia. NUEDEXTA should be discontinued immediately if thrombocytopenia occurs, unless the thrombocytopenia is clearly not drug-related, as continued use increases the risk for fatal hemorrhag ...
... symptoms, such as lightheadedness, chills, fever, nausea, and vomiting, can precede or occur with thrombocytopenia. NUEDEXTA should be discontinued immediately if thrombocytopenia occurs, unless the thrombocytopenia is clearly not drug-related, as continued use increases the risk for fatal hemorrhag ...
Botulinum in the treatment of chronic headache
... pain relievers for more than 3 months to cope with a headache attack or for a syptomatic headache treatment. The therapy for the medication-induced headache involves a withdrawal of the pain relieving drug, undertaking detoxification measures (using glucocorticoids) as a bridge to administration of ...
... pain relievers for more than 3 months to cope with a headache attack or for a syptomatic headache treatment. The therapy for the medication-induced headache involves a withdrawal of the pain relieving drug, undertaking detoxification measures (using glucocorticoids) as a bridge to administration of ...
Antithrombotic agents for the prevention of stroke and
... The Committee noted that there was insufficient evidence to identify a preferred anticoagulation treatment strategy for patients with AF who have a lower risk of stroke (CHADS2 score < 1). For patients with a CHADS2 score of 0, clinical guidelines may be consulted for treatment options based on indi ...
... The Committee noted that there was insufficient evidence to identify a preferred anticoagulation treatment strategy for patients with AF who have a lower risk of stroke (CHADS2 score < 1). For patients with a CHADS2 score of 0, clinical guidelines may be consulted for treatment options based on indi ...
Anxiety Disorders
... Epinephrine and norepinephrine were among the first panic-inducing agents known. Both are secreted in response to stress. Epinephrine stimulates beta-adrenergic receptors, while norepinephrine is a alpha-adrenergic agonist producing peripheral vasoconstriction, increased blood pressure and decreased ...
... Epinephrine and norepinephrine were among the first panic-inducing agents known. Both are secreted in response to stress. Epinephrine stimulates beta-adrenergic receptors, while norepinephrine is a alpha-adrenergic agonist producing peripheral vasoconstriction, increased blood pressure and decreased ...
Bilastine
Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.